FDA Drug Recalls

Recalls / Class II

Class IID-0750-2017

Product

TRI MIX 5.88/17.65/0.588 5ML MDV MCG/MG/MG/ML INJ, , Injection, 5.88mcg/17.65mg/0.588mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Affected lot / code info
Lot # t12-02-2016@100, Exp 5/22/2017; t12-28-2016@104, Exp 6/18/2017.

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling firm

Firm
Key Pharmacy and Compounding Center
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
530 S 336th St, Federal Way, Washington 98003-6383

Distribution

Quantity
3 vials
Distribution pattern
Distributed nationwide in U.S.A., Australia and Canada.

Timeline

Recall initiated
2017-04-18
FDA classified
2017-05-17
Posted by FDA
2017-05-24
Terminated
2017-08-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0750-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.